Clinical Trial

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

Study acronym: INDAPACHLOR
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to test the efficacy of the two long-acting thiazide-like diuretics indapamide and chlorthalidone in reducing urine supersaturation for calcium oxalate and calcium phosphate compared to the short-acting thiazide diuretic hydrochlorothiazide for the prevention of calcium-containing kidney stones.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-26; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2024-10-28
Trial Details
NCT Number NCT06111885
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Conditions Kidney Stone
Enrollment 99 participants
Start Date 2024-10-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-06